Insulinoma in a mixed breed dog: Case report
DOI:
https://doi.org/10.31533/pubvet.v17n12e1499Keywords:
hipoglicemia, insulina, pâncreas, tumorAbstract
Insulinoma is the most common endocrine pancreatic tumor in dogs, characterized by excessive insulin secretion even in the presence of hypoglycemia. Its etiology remains unknown, considered a rare occurrence, and generally malignant. Clinical manifestations result from neuroglycopenia and the release of counterregulatory hormones, manifesting as weakness, seizures, tremors, agitation, and even coma and death. Diagnosis is based on anamnesis, clinical signs, laboratory alterations in blood glucose and fasting serum insulin concentrations, imaging studies such as computed tomography (CT), as well as surgical resection with sample submission for histopathological and immunohistochemical analysis. The primary therapeutic approach is surgical removal of the tumor. This report aims to present the case of a female, six-year-old, mixed-breed canine, spayed, with no history of typical insulinoma signs but with hypoglycemia in a laboratory test and validated portable glucometer. Based on this finding, suspicion of insulinoma arose, leading to investigations involving serum insulin levels and imaging studies. The diagnosis was confirmed by the presence of hyperinsulinemia with hypoglycemia, CT with compatible images and partial pancreatectomy, and tumor was subsequently sent for histopathological and immunohistochemical analysis. The instituted treatment was oral chemotherapy. It was concluded that it is possible to diagnose insulinoma before the appearance of clinical signs, which, despite not altering the reserved prognosis of the disease, allows for more earlier veterinary follow-up, resulting in an improvement in the animal’s quality of life.
References
Bergman, P. J., Bruyette, D. S., Coyne, B. E., Shelton, G. D., Ogilvie, G. K., Munana, K. R., & Richter, K. P. (1994). Canine clinical peripheral neuropathy associated with pancreatic islet cell carcinoma. Progress in Veterinary Neurology, 5, 57–62.
Buishand, F. O. (2022). Current trends in diagnosis, treatment and prognosis of canine insulinoma. Veterinary Sciences, 9(10), 540. https://doi.org/10.3390/vetsci9100540.
Buishand, F. O., Grosso, F. R. V., Kirpensteijn, J., & van Nimwegen, S. A. (2018). Utility of contrast-enhanced computed tomography in the evaluation of canine insulinoma location. Veterinary Quarterly, 38(1), 53–62. https://doi.org/10.1080/01652176.2018.1481545.
Buishand, F. O., Kik, M., & Kirpensteijn, J. (2010). Evaluation of clinico-pathological criteria and the Ki67 index as prognostic indicators in canine insulinoma. The Veterinary Journal, 185(1), 62–67. https://doi.org/10.1016/j.tvjl.2010.04.015.
Carvalho, R., Branquinho, F., Alves, N., Aparício, S., Pires, F., & Dutschmann, L. (2010). Insulinoma: a propósito de um caso clínico com revisão da literatura. Medicina Interna, 2, 99–103.
Caywood, D. D. (1988). Pancreatic insulin-secreting neoplasms: clinical, diagnostic, prognostic features in 73 dogs. Journal American Animal Hospital Association, 24, 577–584.
Del Busto, I., German, A. J., Treggiari, E., Romanelli, G., O’Connell, E. M., Batchelor, D. J., Silvestrini, P., & Murtagh, K. (2020). Incidence of postoperative complications and outcome of 48 dogs undergoing surgical management of insulinoma. Journal of Veterinary Internal Medicine, 34(3), 1135–1143. https://doi.org/10.1111/jvim.15751.
Dunn, J. K., Bostock, D. E., Herrtage, M. E., Jackson, K. F., & Walker, M. J. (1993). Insulin‐secreting tumours of the canine pancreas: clinical and pathological features of 11 cases. Journal of Small Animal Practice, 34(7), 325–331. https://doi.org/10.1111/j.1748-5827.1993.tb02704.x.
Ettinger, S. J., Feldman, E. C., & Cote, E. (2017). Textbook of Veterinary Internal Medicine-eBook. Elsevier Health Sciences.
Feldman, E. C., Nelson, R. W., Reusch, C., & Scott-Moncrieff, J. C. (2014). Canine and feline endocrinology-e-book. Elsevier health sciences.
Garcia, C., Renosto, W., Meira, J., Saccaro, R. O., & Weege, K. (2022). Insulinoma em canino sem raça definida: Relato de caso. PUBVET, 16(2), 1–5. https://doi.org/10.31533/pubvet.v16n02a1047.1-5.
Garden, O. A., Reubi, J. C., Dykes, N. L., Yeager, A. E., McDonough, S. P., & Simpson, K. W. (2005). Somatostatin receptor imaging in vivo by planar scintigraphy facilitates the diagnosis of canine insulinomas. Journal of Veterinary Internal Medicine, 19(2), 168–176. https://doi.org/10.1892/0891-6640(2005)19<168:SRIIVB>2.0.CO;2.
Goutal, C. M., Brugmann, B. L., & Ryan, K. A. (2012). Insulinoma in dogs: a review. Journal of the American Animal Hospital Association, 48(3), 151–163.
Hess, R. S. (2013). Insulinoma. In J. Rand, E. N. Behrend, D. Gunn-Moore, & M. L. Campbell-Ward (Eds.), Clinical endocrinology of companion animals (pp. 229–239). Wiley Blackwell.
Iseri, T., Yamada, K., Chijiwa, K., Nishimura, R., Matsunaga, S., Fujiwara, R., & Sasaki, N. (2007). Dynamic computed tomography of the pancreas in normal dogs and in a dog with pancreatic insulinoma. Veterinary Radiology & Ultrasound, 48(4), 328–331. https://doi.org/10.1111/j.1740-8261.2007.00251.x.
Lamb, C. R., Simpson, K. W., Boswood, A., & Matthewman, L. A. (1995). Ultrasonography of pancreatic neoplasia in the dog: a retrospective review of 16 cases. The Veterinary Record, 137(3), 65–68. https://doi.org/10.1136/vr.137.3.65.
Leifer, C. E., & Matus, R. E. (1985). Lymphoid leukemia in the dog: Acute lymphoblastic leukemia and chronic lymphocytic leukemia. Veterinary Clinics of North America: Small Animal Practice, 15(4), 723–739. https://doi.org/10.1016/s0195-5616(85)50032-7.
Leifer, C. E., Peterson, M. E., & Matus, R. E. (1986). Insulin-secreting tumor: diagnosis and medical and surgical management in 55 dogs. Journal of the American Veterinary Medical Association, 188(1), 60–64.
Madarame, H., Kayanuma, H., Shida, T., & Tsuchiya, R. (2009). Retrospective study of canine insulinomas: eight cases (2005-2008). Journal of Veterinary Medical Science, 71(7), 905–911.
Mai, W., & Cáceres, A. V. (2008). Dual‐phase computed tomographic angiography in three dogs with pancreatic insulinoma. Veterinary Radiology & Ultrasound, 49(2), 141–148. https://doi.org/10.1111/j.1740-8261.2008.00340.x.
Mehlhaff, C. J. (1984). Insulin-producing islet cell neoplasms: surgical considerations and general management in 35 dogs. Journal American Animal Hospital Associationrican, 21, 607–612.
Meleo, K. (1990). Management of insuloma patients with refractory hypoglycemia. Problems in Veterinary Medicine, 2(4), 602–609.
Mooney, C. T., & Peterson, M. E. (2015). Manual de endocrinologia em cães e gatos. Roca Ltda.
Nakamura, K., Lim, S., Ochiai, K., Yamasaki, M., Ohta, H., Morishita, K., Takagi, S., & Takiguchi, M. (2015). Contrast‐enhanced ultrasonographic findings in three dogs with pancreatic insulinoma. Veterinary Radiology & Ultrasound, 56(1), 55–62. https://doi.org/10.1111/ vru.12177.
Northrup, N., Rassnick, K. M., Gieger, T. L., Kosarek, C. E., McFadden, C. W., & Rosenberg, M. P. (2013). Prospective evaluation of biweekly streptozotocin in 19 dogs with insulinoma. Journal of Veterinary IIternal Medicine, 27(3), 483–490. https://doi.org/10.1111/jvim.12086.
Polton, G., White, R. N., Brearley, M. J., & Eastwood, J. M. (2007). Improved survival in a retrospective cohort of 28 dogs with insulinoma. Journal of Small Animal Practice, 48(3), 151–156. https://doi.org/10.1111/j.1748-5827.2006.00187.x.
Pöppl, A. G. (2015). Insulinoma. In M. M. Jericó, J. P. Andrade Neto, & M. M. Kogika (Eds.), Tratado de medicina interna de cães e gatos (1a ed., pp. 5233–5268). Roca, São Paulo.
Robben, J. H., Pollak, Y. W. E. A., Kirpensteijn, J., Boroffka, S. A. E. B., van den Ingh, T. S., Teske, E., & Voorhout, G. (2005). Comparison of ultrasonography, computed tomography, and single‐photon emission computed tomography for the detection and localization of canine insulinoma. Journal of Veterinary Internal Medicine, 19(1), 15–22. https://doi.org/10.1892/0891-6640(2005)19<15:COUCTA>2.0.CO;2.
Sheppard‐Olivares, S., Bello, N. M., Johannes, C. M., Hocker, S. E., Biller, B., Husbands, B., Snyder, E., McMillan, M., McKee, T., & Wouda, R. M. (2022). Toceranib phosphate in the management of canine insulinoma: A retrospective multicentre study of 30 cases (2009–2019). Veterinary Record Open, 9(1), e27. https://doi.org/10.1002/vro2.27.
Slatter, D. H. (2003). Textbook of small animal surgery (Vol. 1). Elsevier health sciences.
Steiner, J. M. (2003). Diagnosis of pancreatitis. Veterinary Clinics: Small Animal Practice, 33(5), 1181–1195. https://doi.org/10.1016/S0195-5616(03)00061-5.
Steiner, J. M. (2008). Exocrine pancreas. Small Animal Gastroenterology, 283–306.
Tobin, R. L., Nelson, R. W., Lucroy, M. D., Wooldridge, J. D., & Feldman, E. C. (1999). Outcome of surgical versus medical treatment of dogs with beta cell neoplasia: 39 cases (1990-1997). Journal of the American Veterinary Medical Association, 215(2), 226–230.
Trifonidou, M. A., Kirpensteijn, J., & Robben, J. H. (1998). A retrospective evaluation of 51 dogs with insulinoma. Veterinary Quarterly, 20(sup1), S114–S115. https://doi.org/10.1080/01652176.1998.10807459.
Downloads
Published
Issue
Section
License
Copyright (c) 2023 Laís Souza Carvalho, José Francisco Antunes Ribeiro, Liliana Reis Rosa, Luiz Carlos de Castilho Júnior, Egle de Moura Pelegrini
This work is licensed under a Creative Commons Attribution 4.0 International License.
Você tem o direito de:
Compartilhar — copiar e redistribuir o material em qualquer suporte ou formato
Adaptar — remixar, transformar, e criar a partir do material para qualquer fim, mesmo que comercial.
O licenciante não pode revogar estes direitos desde que você respeite os termos da licença. De acordo com os termos seguintes:
Atribuição
— Você deve dar o crédito apropriado, prover um link para a licença e indicar se mudanças foram feitas. Você deve fazê-lo em qualquer circunstância razoável, mas de nenhuma maneira que sugira que o licenciante apoia você ou o seu uso. Sem restrições adicionais
— Você não pode aplicar termos jurídicos ou medidas de caráter tecnológico que restrinjam legalmente outros de fazerem algo que a licença permita.